These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 22773690

  • 1. IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.
    Josephson MB, Jiao J, Xu S, Hu A, Paranjape C, Grunstein JS, Grumbach Y, Nino G, Kreiger PA, McDonough J, Grunstein MM.
    Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(5):L382-90. PubMed ID: 22773690
    [Abstract] [Full Text] [Related]

  • 2. Th2 cytokine-induced upregulation of 11beta-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function.
    Hu A, Fatma S, Cao J, Grunstein JS, Nino G, Grumbach Y, Grunstein MM.
    Am J Physiol Lung Cell Mol Physiol; 2009 May; 296(5):L790-803. PubMed ID: 19251840
    [Abstract] [Full Text] [Related]

  • 3. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
    Garbrecht MR, Schmidt TJ, Krozowski ZS, Snyder JM.
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
    [Abstract] [Full Text] [Related]

  • 4. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ, Park SJ, Kim TH, Lee SH, Lee KJ, Hwang SM, Lee SH.
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
    Jun YJ, Park SJ, Hwang JW, Kim TH, Jung KJ, Jung JY, Hwang GH, Lee SH, Lee SH.
    Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
    [Abstract] [Full Text] [Related]

  • 6. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR.
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [Abstract] [Full Text] [Related]

  • 7. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH, Kim HJ, Kim KW, Park SJ, Kim TH, Lim SH, Kang SH, Lee SH.
    Am J Rhinol Allergy; 2015 Dec; 29(4):246-50. PubMed ID: 26163245
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV, Vuorinen A, Da Cunha T, Wolber G, Classen-Houben D, Doblhoff O, Schuster D, Odermatt A.
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
    Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI, Stewart PM.
    QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
    [Abstract] [Full Text] [Related]

  • 14. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M, Holleran G, Smith S, Sherlock M, McNamara D.
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [Abstract] [Full Text] [Related]

  • 15. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ, Latif SA, Hardy MP, Brem AS.
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [Abstract] [Full Text] [Related]

  • 18. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
    Gong R, Morris DJ, Brem AS.
    Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
    [Abstract] [Full Text] [Related]

  • 19. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S, Carreiro S, Quenzer T, Gale D, Xiang C, Gukasyan H, Lafontaine J, Cheng H, Krauss A, Prasanna G.
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [Abstract] [Full Text] [Related]

  • 20. Local and systemic glucocorticoid metabolism in inflammatory arthritis.
    Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, Gittoes NJ, Buckley CD, Raza K, Cooper MS.
    Ann Rheum Dis; 2008 Sep; 67(9):1204-10. PubMed ID: 18420938
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.